16
Aug
Aug
What Is Retatrutide? The Next Breakthrough in Weight Loss and Diabetes Treatment Retatrutide is an experimental triple-hormone agonist developed by Eli Lilly, targeting the GIP, GLP-1, and glucagon receptors to enhance weight loss and blood sugar control. Early clinical trials show unprecedented results, with participants losing up to 24% of their body weight surpassing current drugs like Wegovy (semaglutide) […]